Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?
about
Protocadherin 17 promoter methylation in tumour tissue from patients with bladder transitional cell carcinomaBladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22.A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace.[Urine cytology - update 2013. A systematic review of recent literature].The prognostic role of pre-cystectomy hemoglobin levels in patients with invasive bladder cancer.[Non-muscle-invasive high-grade bladder cancer].
P2860
Can the burden of follow-up in low-grade noninvasive bladder cancer be reduced by photodynamic diagnosis, perioperative instillations, imaging, and urine markers?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Can the burden of follow-up in ...... s, imaging, and urine markers?
@en
Can the burden of follow-up in ...... s, imaging, and urine markers?
@nl
type
label
Can the burden of follow-up in ...... s, imaging, and urine markers?
@en
Can the burden of follow-up in ...... s, imaging, and urine markers?
@nl
prefLabel
Can the burden of follow-up in ...... s, imaging, and urine markers?
@en
Can the burden of follow-up in ...... s, imaging, and urine markers?
@nl
P1476
Can the burden of follow-up in ...... s, imaging, and urine markers?
@en
P2093
Arnulf Stenzl
Georgios Gakis
P304
P356
10.1097/MOU.0B013E32833CC9F4
P577
2010-09-01T00:00:00Z